An Q, Huang L, Wang C, Wang D, Tu Y
Front Pharmacol. 2025; 16:1550158.
PMID: 40008135
PMC: 11850385.
DOI: 10.3389/fphar.2025.1550158.
Nortje N, Aribisala J, Pillay C, Sabiu S
Arch Microbiol. 2025; 207(3):53.
PMID: 39921728
PMC: 11807064.
DOI: 10.1007/s00203-025-04240-3.
Kurt H, Akyol A, Son C, Zheng C, Gado I, Meli M
bioRxiv. 2024; .
PMID: 39713392
PMC: 11661165.
DOI: 10.1101/2024.12.12.628161.
Alkhatabi H, Alatyb H
Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338345
PMC: 11435111.
DOI: 10.3390/ph17091183.
Mihalovits L, Szalai T, Bajusz D, Keseru G
J Chem Inf Model. 2024; 64(23):8963-8979.
PMID: 39305268
PMC: 11632764.
DOI: 10.1021/acs.jcim.4c00803.
Structure-based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach.
Islam S, Al Amin M, Rengasamy K, Mohiuddin A, Mahmud S
Cancer Med. 2024; 13(15):e70074.
PMID: 39101505
PMC: 11299079.
DOI: 10.1002/cam4.70074.
Peptide and Peptidomimetic Inhibitors Targeting the Interaction of Collapsin Response Mediator Protein 2 with the N-Type Calcium Channel for Pain Relief.
Perez-Miller S, Gomez K, Khanna R
ACS Pharmacol Transl Sci. 2024; 7(7):1916-1936.
PMID: 39022365
PMC: 11249630.
DOI: 10.1021/acsptsci.4c00181.
Identification of Druggable Binding Sites and Small Molecules as Modulators of TMC1.
De-la-Torre P, Martinez-Garcia C, Gratias P, Mun M, Santana P, Akyuz N
bioRxiv. 2024; .
PMID: 38826329
PMC: 11142246.
DOI: 10.1101/2024.03.05.583611.
Identification and characterization of small molecule inhibitors of the LINE-1 retrotransposon endonuclease.
DOrdine A, Jogl G, Sedivy J
Nat Commun. 2024; 15(1):3883.
PMID: 38719805
PMC: 11078990.
DOI: 10.1038/s41467-024-48066-x.
In silico exploration of phenolics as modulators of penicillin binding protein (PBP) 2× of Streptococcus pneumoniae.
Aribisala J, Sthebe N, Sabiu S
Sci Rep. 2024; 14(1):8788.
PMID: 38627456
PMC: 11021432.
DOI: 10.1038/s41598-024-59489-3.
Inhibition of a conserved bacterial dual-specificity phosphatase confers plant tolerance to Liberibacter spp.
Wang H, Irigoyen S, Liu J, Ramasamy M, Padilla C, Bedre R
iScience. 2024; 27(3):109232.
PMID: 38425843
PMC: 10904284.
DOI: 10.1016/j.isci.2024.109232.
Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies.
Fouad M, Osman A, Abdelhamid N, Rashad M, Nabawy A, El Kerdawy A
BMC Chem. 2024; 18(1):29.
PMID: 38347617
PMC: 10863211.
DOI: 10.1186/s13065-024-01130-5.
Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX.
Saravanan V, Chagaleti B, Packiapalavesam S, Kathiravan M
RSC Adv. 2024; 14(5):3346-3358.
PMID: 38259989
PMC: 10801456.
DOI: 10.1039/d3ra08618f.
Identification of Novel EGFR Inhibitors for the Targeted Therapy of Colorectal Cancer Using Pharmacophore Modelling, Docking, Molecular Dynamic Simulation and Biological Activity Prediction.
Krishnan K A, Valavi S, Joy A
Anticancer Agents Med Chem. 2024; 24(4):263-279.
PMID: 38173208
DOI: 10.2174/0118715206275566231206094645.
Discovery of dual rho-associated protein kinase 1 (ROCK1)/apoptosis signal-regulating kinase 1 (ASK1) inhibitors as a novel approach for non-alcoholic steatohepatitis (NASH) treatment.
Zaky Y, Rashad M, Zaater M, El Kerdawy A
BMC Chem. 2024; 18(1):2.
PMID: 38172941
PMC: 10765837.
DOI: 10.1186/s13065-023-01081-3.
Proposition of Pharmacophore Models for Malaria: A Review.
de Sousa N, de Araujo I, Rodrigues T, da Silva P, de Moura J, Scotti M
Comb Chem High Throughput Screen. 2023; 27(17):2525-2543.
PMID: 37815185
DOI: 10.2174/0113862073247691230925062440.
Ferroptosis Mediated Novel Drug Design Approach in the Treatment of Oral Squamous Cell Carcinoma.
S D, Ramani P, Doble M, Ramasubramanian A
Asian Pac J Cancer Prev. 2023; 24(7):2321-2327.
PMID: 37505762
PMC: 10676479.
DOI: 10.31557/APJCP.2023.24.7.2321.
A Chemical Proteomic Strategy Reveals Inhibitors of Lipoate Salvage in Bacteria and Parasites.
Dienemann J, Chen S, Hitzenberger M, Sievert M, Hacker S, Prigge S
Angew Chem Int Ed Engl. 2023; 62(31):e202304533.
PMID: 37249408
PMC: 10896624.
DOI: 10.1002/anie.202304533.
Molecular Structural Analysis of Porcine CMAH-Native Ligand Complex and High Throughput Virtual Screening to Identify Novel Inhibitors.
Ogun O, Thaller G, Becker D
Pathogens. 2023; 12(5).
PMID: 37242354
PMC: 10220980.
DOI: 10.3390/pathogens12050684.
MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference.
Durojaye O, Okoro N, Odiba A, Nwanguma B
Sci Rep. 2023; 13(1):6972.
PMID: 37117213
PMC: 10141821.
DOI: 10.1038/s41598-023-33024-2.